U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C26H18ClN3O2
Molecular Weight 439.893
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ENTASOBULIN

SMILES

ClC1=CC=C(CN2C=C(C(=O)C(=O)NC3=CC=C4N=CC=CC4=C3)C5=C2C=CC=C5)C=C1

InChI

InChIKey=LJIUXAHLYIPHOK-UHFFFAOYSA-N
InChI=1S/C26H18ClN3O2/c27-19-9-7-17(8-10-19)15-30-16-22(21-5-1-2-6-24(21)30)25(31)26(32)29-20-11-12-23-18(14-20)4-3-13-28-23/h1-14,16H,15H2,(H,29,32)

HIDE SMILES / InChI

Molecular Formula C26H18ClN3O2
Molecular Weight 439.893
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Entasobulin (ZEN-012; AEZS-112) is a small molecule with several mechanisms of action, such as DNA fragmentation via inhibition of topoisomerase II as well as inhibition of tubulin polymerization. It exerts antineoplastic activity. It was being developed for the treatment of cancers.

Approval Year

PubMed

PubMed

TitleDatePubMed
Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC).
2015-09
Tubulin inhibitor AEZS 112 inhibits the growth of experimental human ovarian and endometrial cancers irrespective of caspase inhibition.
2009-08
Patents

Patents

Sample Use Guides

Entasobulin showed anti-tumor activity in human ovarian and endometrial cancer cell lines at low micromolar concentrations
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:33:36 GMT 2025
Edited
by admin
on Mon Mar 31 18:33:36 GMT 2025
Record UNII
TB77GU6BFO
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
entasobulin [INN]
Preferred Name English
ENTASOBULIN
INN   WHO-DD  
INN  
Official Name English
Entasobulin [WHO-DD]
Common Name English
2-(1-(4-CHLOROBENZYL)-1H-INDOL-3-YL)-2-OXO-N-CHINOLIN-6-YL-ACETAMIDE
Code English
2-(1-(4-CHLOROBENZYL)-1H-INDOL-3-YL)-2-OXO-N-QUINOLIN-6-YLACETAMIDE
Systematic Name English
1H-INDOLE-3-ACETAMIDE, 1-((4-CHLOROPHENYL)METHYL)-.ALPHA.-OXO-N-6-QUINOLINYL-
Systematic Name English
Code System Code Type Description
DRUG BANK
DB06042
Created by admin on Mon Mar 31 18:33:36 GMT 2025 , Edited by admin on Mon Mar 31 18:33:36 GMT 2025
PRIMARY
CAS
501921-61-5
Created by admin on Mon Mar 31 18:33:36 GMT 2025 , Edited by admin on Mon Mar 31 18:33:36 GMT 2025
PRIMARY
SMS_ID
300000036989
Created by admin on Mon Mar 31 18:33:36 GMT 2025 , Edited by admin on Mon Mar 31 18:33:36 GMT 2025
PRIMARY
FDA UNII
TB77GU6BFO
Created by admin on Mon Mar 31 18:33:36 GMT 2025 , Edited by admin on Mon Mar 31 18:33:36 GMT 2025
PRIMARY
PUBCHEM
10203597
Created by admin on Mon Mar 31 18:33:36 GMT 2025 , Edited by admin on Mon Mar 31 18:33:36 GMT 2025
PRIMARY
INN
9847
Created by admin on Mon Mar 31 18:33:36 GMT 2025 , Edited by admin on Mon Mar 31 18:33:36 GMT 2025
PRIMARY
NCI_THESAURUS
C169953
Created by admin on Mon Mar 31 18:33:36 GMT 2025 , Edited by admin on Mon Mar 31 18:33:36 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY